News

artificial intelligence pharmaceutical industry
Q&A: Proposed changes to Social Security Act would recognize pharmacists as healthcare providers

Pharmacist Jason Ausili discusses the expanding role of pharmacies as one-stop-shop patient care centers for every community.

venture capital AI investments
10 signs AI is ‘eating the world (of venture capital)’

Some investment analysts are predicting a more permissive M&A market, deregulation as a catalyst for growth and fiscal policies that stimulate economic activity. And they see AI as a catalyst in the shift. 

Luigi Mangione Mugshot Pennsylvania
Mangione now faces federal charges, death penalty in murder of UHC CEO

After Luigi Mangione, the man accused of killing UnitedHealthcare CEO Brian Thompson, was extradited to New York, federal prosecutors unsealed a new set of murder charges. 

FDA issues Class I recall on counterfeit infusion pump batteries

ICU Medical alerted customers to knockoff batteries being circulated by suppliers. Due to a risk of the batteries not holding a charge, the recall has been given the FDA’s most serious designation. 

FDA warning alert exclamation computer
FDA issues alert on PCNL sheath safety after patient death

Trokamed sent a letter to customers warning them to never use its Mini PCNL Sheaths for suction and irrigation, due to a risk of kidney rupture. 

PHOTO GALLERY: Medical imaging technology at RSNA 2024

Take a virtual tour around the Radiological Society of North America (RSNA) meeting to see the sights and new technologies displayed across the vast exhibit hall floors.

FBI seeking extradition of Israeli prisoner accused of $500M in ransomware attacks

Rostislav Panev is facing fraud and cybercrime charges in Israel, where he has been accused of being a software developer for hacker group LockBit.

CVS Health announces $10.6B acquisition of Oak Street Health
DOJ sues CVS over unlawful opioid prescriptions and reimbursement

The U.S. Department of Justice said policies at CVS Health forbade pharmacists from discussing patients and providers who may be prescribing opiates in violation of the Controlled Substance Act. 

healthcare insurance fraud scam scheme legal lawsuit
Texas clinics face potential $300M fine for submitting 20K false claims

A jury found Healthcare Associates of Texas guilty of knowingly submitting tens of thousands of fraudulent claims to Medicare, costing the government more than $2.8 million. 

medical debt
Report: 44% of adults in the U.S. are uninsured or underinsured

According to an analysis from the Commonwealth Fund, millions of patients are skipping necessary care and struggling to pay mounting medical debt. 

Compensation for U.S. cardiologists is up across the board, according to a recent survey published by MedAxiom, an American College of Cardiology company. The report identified similar trends for cardiovascular surgeons, highlighting the country’s high demand for all heart specialists in 2024 and beyond.
Q&A: MedAxiom CEO explores key trends in cardiologist, cardiovascular surgeon compensation

Compensation for heart specialists continues to climb. What does this say about cardiology as a whole? Could private equity's rising influence bring about change? We spoke to MedAxiom CEO Jerry Blackwell, MD, MBA, a veteran cardiologist himself, to learn more.

patient engagement satisfaction
5 ways to let AI raise patient satisfaction, elevate provider performance

It’s been years since AI proponents started promising big returns on healthcare providers’ investments in the technology. The results have yet to catch up with the pitches. What’s the holdup? 

Around the web

AI in Healthcare
10 signs AI is ‘eating the world (of venture capital)’

Some investment analysts are predicting a more permissive M&A market, deregulation as a catalyst for growth and fiscal policies that stimulate economic activity. And they see AI as a catalyst in the shift. 

Health Imaging
PHOTO GALLERY: Medical imaging technology at RSNA 2024

Take a virtual tour around the Radiological Society of North America (RSNA) meeting to see the sights and new technologies displayed across the vast exhibit hall floors.

Cardiovascular Business
FDA says years-long tirzepatide shortage is resolved, will give limited leeway to compounders

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.